| Schedule of segment profit or loss, including segment expenses |
The table below is a summary of the segment profit or loss, including significant segment expenses (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2024 |
|
|
2023 |
|
Collaboration revenue |
|
$ |
13,631 |
|
|
$ |
63,533 |
|
Less: |
|
|
|
|
|
|
Personnel costs |
|
|
43,684 |
|
|
|
63,454 |
|
Clinical programs |
|
|
25,818 |
|
|
|
40,289 |
|
Research activities |
|
|
14,692 |
|
|
|
18,768 |
|
Facilities costs |
|
|
26,648 |
|
|
|
26,005 |
|
Other segment expenses (1) |
|
|
113,065 |
|
|
|
105,528 |
|
Total operating expenses |
|
|
223,907 |
|
|
|
254,044 |
|
Loss from operations |
|
|
(210,276 |
) |
|
|
(190,511 |
) |
Other income (expense): |
|
|
|
|
|
|
Interest income |
|
|
17,288 |
|
|
|
17,186 |
|
Change in fair value of stock price appreciation milestones |
|
|
819 |
|
|
|
2,515 |
|
Other income |
|
|
5,907 |
|
|
|
9,882 |
|
Total other income |
|
|
24,014 |
|
|
|
29,583 |
|
Net loss |
|
$ |
(186,262 |
) |
|
$ |
(160,928 |
) |
(1) Other segment expenses include stock compensation expense, depreciation, legal fees, general & administrative expenses, and corporate expenses.
|